AxoGen Inc reports results for the quarter ended in December - Earnings Summary

AxoGen

05/03/2024 23:41

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 6
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -3
cents.  The mean expectation of five analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -16 cents to -1 cents per share.
    * Revenue rose 18.7% to $42.92 million from a year ago;
analysts
expected $41.65 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 9
cents​.
    * The company reported a quarterly loss of $3.89 million.
    * AxoGen Inc shares had risen by 55.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 10% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for AxoGen Inc is
$13.00 
This summary was machine generated from LSEG data March 5 at
11:41 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.10          -0.06          Beat
 Sep. 30 2023      -0.06          0.01           Beat
 Jun. 30 2023      -0.13          -0.03          Beat
 Mar. 31 2023      -0.14          -0.10          Beat